Albero Pharma Private Limited
About Albero Pharma Private Limited
Data last updated:
Albero Pharma Private Limited is a private limited company based in Valsad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33112GJ2018PTC104775. Its GSTIN is 24AARCA4682N1Z0 (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Chandraben Hiralal Thakkar and Vishal Rajendrabhai Chaudhari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P – 491/2 492 1 2 3 Shop No. 105 Amidhara Complex GIDC Vapi Pardi Valsad, Gujarat, India – 396195.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.08 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹2.54 Lakh (net margin 2.4%) and EBITDA of ₹4.18 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 20% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Albero Pharma Private Limited's registered office is in Valsad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressP – 491/2 492 1 2 3 Shop No. 105 Amidhara Complex GIDC Vapi Pardi Valsad, Gujarat, India – 396195
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Albero Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Albero Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Albero Pharma Private Limited, buy the company report.
Financials of Albero Pharma Private Limited
FY 2025 filings availableAlbero Pharma Private Limited reported revenue of ₹1.08 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 9% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Albero Pharma Private Limited, buy the company report.
Board of directors of Albero Pharma Private Limited
Albero Pharma has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandraben Hiralal Thakkar | Director | 11 May 2021 | 5 Years 5 Months | Current |
| Vishal Rajendrabhai Chaudhari | Director | 14 Nov 2018 | 7 Years 11 Months | Current |
| Karunendra Pandey | Director | 16 Oct 2018 | 8 Years 0 Months | Current |
| Anant Gamanlal Chaudhari Also directs: Varah Sitaram Farmer Producer Company Limited | Director | 29 Mar 2023 | 3 Years 7 Months | Current |
| Umaben Rajankumar Thakar | Director | 19 Aug 2021 | 5 Years 2 Months | Current |
Shareholding
The shareholding of Albero Pharma Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Albero Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Albero Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Albero Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Albero Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AARCA4682N1Z0 | Gujarat | Active | 04 Dec 2018 |
To see the full GST registrations and return filing status of Albero Pharma Private Limited, buy the company report.
Recent activity
Albero Pharma Private Limited has 12 board changes on record since 2018: 5 appointments and 7 cessations. The latest: Anant Gamanlal Chaudhari ceased to be Additional Director on 29 Sep 2023.
3 earlier events are in the company report.
Frequently asked questions
Albero Pharma is an active private limited company based in Valsad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 October 2018 (8+ years old) and is registered under CIN U33112GJ2018PTC104775.
Albero Pharma has 5 current directors:
- Chandraben Hiralal Thakkar - Director
- Vishal Rajendrabhai Chaudhari - Director
- Karunendra Pandey - Director
- Anant Gamanlal Chaudhari - Director
- Umaben Rajankumar Thakar - Director
The latest financial statements of Albero Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Albero Pharma is 24AARCA4682N1Z0, registered in Gujarat.
The CIN (Corporate Identification Number) of Albero Pharma is U33112GJ2018PTC104775. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Albero Pharma was incorporated on 16 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Anant Gamanlal Chaudhari ceased to be Additional Director on 29 Sep 2023. Anant Gamanlal Chaudhari was appointed as Director on 29 Mar 2023. Chandraben Hiralal Thakkar ceased to be Additional Director on 30 Sep 2022. Albero Pharma has 12 board changes on record in total.
The registered office of Albero Pharma is at P – 4912 492 1 2 3 Shop No. 105 Amidhara Complex GIDC Vapi Pardi Valsad, Gujarat, India – 396195.
Albero Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Albero Pharma is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
